Open Access
BIO Web Conf.
Volume 75, 2023
The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2023)
Article Number 05011
Number of page(s) 6
Section Big Data for Public Health Policy
Published online 15 November 2023
  • Farah FH. Schizophrenia: An Overview. Asian J Pharm. 2018; 12(2):77–87. [Google Scholar]
  • Gaebel W, Zielasek J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry Clin Neurosci. 2015; 1–13. [PubMed] [Google Scholar]
  • Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, de Hert M. Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200–18. [CrossRef] [PubMed] [Google Scholar]
  • Joseph B, Narayanaswamy JC, Venkatasubramanian G. Insight in Schizophrenia : Relationship to Positive, Negative and Neurocognitive Dimensions. Indian J Psychol Med. 2015;37(1):5–11. [CrossRef] [PubMed] [Google Scholar]
  • Dobber J, Latour C, de Haan L, Scholte op Reimer W, Peters R, Barkhof E, van Meijel B. Medication adherence in patients with schizophrenia: A qualitative study of the patient process in motivational interviewing. BMC Psychiatry. 2018 May 18;18(1). [CrossRef] [PubMed] [Google Scholar]
  • Fervaha G, Foussias G, Agid O, Remington G. Motivational deficits in early schizophrenia : Prevalent, persistent, and key determinants of functional outcome. Schizophr Res [Internet]. 2015;166:9–16. Available from: [CrossRef] [Google Scholar]
  • Foussias G, Siddiqui I, Fervaha G, Mann S, Mcdonald K, Agid O. Motivated to do well : An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia. Schizophr Res [Internet]. 2015;166:276–82. Available from: [CrossRef] [Google Scholar]
  • Phan S V. Medication adherence in patients with schizophrenia. Int J Psychiatry Med. 2016 Feb 1;51(2):211–9. [CrossRef] [PubMed] [Google Scholar]
  • Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 Sep;353(12):1209–23. [CrossRef] [PubMed] [Google Scholar]
  • Najas-garcia A, Carmona VR, Gomez-Benito J. Trends in the Study of Motivation in Schizophrenia : A Bibliometric Analysis of Six Decades of Research (1956-2017). Front Psychol. 2018;9(February):1–16. [PubMed] [Google Scholar]
  • Roberts DL, Velligan DI. Medication adherence in schizophrenia. Drug Discov Today Ther Strateg [Internet]. 2011;8(1):11–5. Available from: [CrossRef] [Google Scholar]
  • Chapman SCE, Horne R. Medication nonadherence and psychiatry. Curr Opin Psychiatry. 2013;26(5):446–52. [CrossRef] [PubMed] [Google Scholar]
  • Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet (London, England). 2012 Jun;379(9831):2063–71. [CrossRef] [PubMed] [Google Scholar]
  • Fiszdon JM, Kurtz MM, Choi J, Bell MD, Martino S. Motivational interviewing to increase cognitive rehabilitation adherence in schizophrenia. Schizophr Bull. 2016;42(2):327–34. [CrossRef] [PubMed] [Google Scholar]
  • Gray R, Wykes T, Gournay K. From compliance to concordance : a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs. 2002;9:277–84. [CrossRef] [PubMed] [Google Scholar]
  • Gray R, White J, Schulz M, Abderhalden C. Enhancing medication adherence in people with schizophrenia: an international programme of research. Int J Ment Health Nurs. 2010 Feb;19(1):36–44. [CrossRef] [PubMed] [Google Scholar]
  • Harmanci P, Budak FK. The Effect of Psychoeducation Based on Motivational Interview Techniques on Medication Adherence, Hope, and Psychological WellBeing in Schizophrenia Patients. Clin Nurs Res [Internet]. 2022 Oct 1;31(2):202–16. Available from: [CrossRef] [PubMed] [Google Scholar]
  • Chien WT, Mui JHC, Cheung EFC, Gray R. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: A randomized controlled trial. Trials. 2015;16(1). [CrossRef] [PubMed] [Google Scholar]
  • Ertem MY, Duman ZÇ. The effect of motivational interviews on treatment adherence and insight levels of patients with schizophrenia: A randomized controlled study. Perspect Psychiatr Care. 2019;55(1):75–86. [CrossRef] [PubMed] [Google Scholar]
  • Chien WT, Cheung EFC, Mui JHC, Gray R, Ip G. Adherence therapy for schizophrenia: a randomised controlled trial. Hong Kong Med J. 2019 Feb;25 Suppl 2(1):4–9. [Google Scholar]
  • Barkhof E, Meijer CJ, De Sonneville LMJ, Linszen DH, De Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr Bull. 2013;39(6):1242–51. [CrossRef] [PubMed] [Google Scholar]
  • Miller WR, Rollnick S. Motivational Interviewing Helping People Change. Third Edit. New York: The Guilford Press; 2013. 1–615p. [Google Scholar]
  • Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, Rollnick S. Motivational interviewing in medical care settings : A systematic review and metaanalysis of randomized controlled trials. Patient Educ Couns [Internet]. 2013;93:157–68. Available from: [CrossRef] [Google Scholar]
  • Szczekala K, Wiktor K, Kanadys K, Wiktor H. Benefits of Motivational Interviewing application for patients and healthcare professionals. Pol J Public Heal. 2018;128(4):170–3. [CrossRef] [Google Scholar]
  • Bischof G, Bischof A, Rumpf H. Motivational Interviewing : An Evidence-Based Approach for Use in Medical Practice. Dtsch Artebl Int. 2021;118:109–15. [Google Scholar]
  • Vanderwaal FM. Impact of Motivational Interviewing on Medication Adherence in Schizophrenia. Issues Ment Health Nurs. 2015;36(11):900–4. [CrossRef] [PubMed] [Google Scholar]
  • Keeley RD, Burke BL, Brody D, Dimidjian S. Training to Use Motivational Interviewing Techniques for Depression : A Cluster Randomized Trial. 2014;000156:621–36. [Google Scholar]
  • Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational Interviewing Improves Medication Adherence : a Systematic Review and Meta-analysis. J Gen Intern Med [Internet]. 2016;31(8):929–40. Available from: [CrossRef] [PubMed] [Google Scholar]
  • Dobber J, Latour C, van Meijel B, ter Riet G, Barkhof E. Active Ingredients and Mechanisms of Change in Motivational Interviewing for Medication Adherence. A Mixed Methods Study of Patient-Therapist Interaction in Patients With Schizophrenia. Front Psychiatry. 2020;11:1–12. [Google Scholar]
  • Madson MB, Loignon AC, Lane C. Training in motivational interviewing : A systematic review. J Subst Abuse Treat [Internet]. 2009;36:101–9. Available from: [CrossRef] [Google Scholar]
  • Miller WR, Rollnick S. Ten Things that Motivational Interviewing Is Not. Behav Cogn Psychother. 2009;37:129–40. [CrossRef] [PubMed] [Google Scholar]
  • Bell DL, Roomaney R. Exploring the barriers that prevent practitioners from implementing motivational interviewing in their work with clients. Soc Work. 2020;56(4):416–29. [Google Scholar]
  • Gray R, Bressington D, Ivanecka A, Hardy S, Jones M, Schulz M, von Bormann S, White J, Anderson KH, Chien W. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis. BMC Psychiatry. 2016;16(90):1–12. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.